K D Mullen
Overview
Explore the profile of K D Mullen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1074
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanyal A, Younossi Z, Bass N, Mullen K, Poordad F, Brown R, et al.
Aliment Pharmacol Ther
. 2011 Aug;
34(8):853-61.
PMID: 21848797
Background: Hepatic encephalopathy (HE) is a brain disorder that often results from cirrhosis due to viral hepatitis, metabolic and alcohol-related liver disease, and is characterised by cognitive, psychiatric and motor...
2.
Bajaj J, Cordoba J, Mullen K, Amodio P, Shawcross D, Butterworth R, et al.
Aliment Pharmacol Ther
. 2011 Feb;
33(7):739-47.
PMID: 21306407
Background: The clinical classification of hepatic encephalopathy is largely subjective, which has led to difficulties in designing trials in this field. Aims: To review the current classification of hepatic encephalopathy...
3.
Mullen K
Aliment Pharmacol Ther
. 2007 Feb;
25 Suppl 1:11-6.
PMID: 17295847
The heterogeneity and variability of the manifestations of hepatic encephalopathy among patients and in individual patients over time make the condition difficult to diagnose and to categorize with respect to...
4.
Sanaka M, Super D, Mullen K, Ferguson D, McCullough A
Aliment Pharmacol Ther
. 2006 Feb;
23(5):669-74.
PMID: 16480406
Background: Polyethylene glycol electrolyte solution (PEG-EL) used for colonoscopy preparation is not well tolerated by several patients. A significant number of patients have inadequate bowel preparation despite taking PEG-EL. Aims:...
5.
Ramasubbu K, Mullick T, Koo A, Hussein M, Henderson J, Mullen K, et al.
Transpl Infect Dis
. 2003 Sep;
5(2):98-103.
PMID: 12974791
Background: Thrombotic microangiopathy (TMA) is a rare but potentially lethal complication encountered in solid organ and bone marrow transplant recipients, requiring rapid recognition, diagnosis, and initiation of therapy. Several potential...
6.
Rosenblum D, Geisinger M, Newman J, Boden T, Markowitz D, Powell D, et al.
J Vasc Interv Radiol
. 2001 Nov;
12(11):1343-6.
PMID: 11698635
To assess the feasibility of peritoneal ports for management of patients with cirrhotic refractory ascites, 10 ports were placed in nine patients for frequent outpatient paracentesis. Retrospective review and telephone...
7.
Kramer L, Gendo A, Madl C, Mullen K, Sunder-Plassmann G, Schaffer A, et al.
Int J Artif Organs
. 2001 Aug;
24(7):434-42.
PMID: 11510914
To investigate the role of extracorporeal detoxification in cirrhotic patients with advanced hepatic encephalopathy not responding to medical treatment, 20 patients were randomized to receive six hours of additional sorbent...
8.
Ong J, Mullen K
Eur J Gastroenterol Hepatol
. 2001 May;
13(4):325-34.
PMID: 11338058
In the last decade, a significant amount of research has been devoted to the pathogenesis and treatment of hepatic encephalopathy (HE). Non-invasive neuroimaging techniques such as magnetic resonance imaging and...
9.
Kyprianou A, Hanna J, Mullen K
Am J Gastroenterol
. 2001 Mar;
96(2):273-4.
PMID: 11232663
No abstract available.
10.
Younossi Z, Mullen K, Zakko W, Hodnick S, Brand E, Barnes D, et al.
J Hepatol
. 2001 Feb;
34(1):128-33.
PMID: 11211889
Background/aims: Interferon-based regimens (alone or with ribavairin) are standard therapies for chronic hepatitis C. The aim of this study was to compare a 24-week regimen of interferon alpha-2b + ribavirin...